AI Drug Discovery Hits $60B Inflection Point

AI-Powered Drug Discovery: The $60B Inflection Point Reshaping Pharmaceutical Innovation The pharmaceutical industry stands at a remarkable inflection point. After years of hype and proof-of-concepts, 2026 marks the first cycle where AI-native drug d...